U.S., Sept. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07152873) titled 'A Study to Compare to PK Characteristics and Safety Profiles Between AD-117 and AD-117A' on Aug. 26.
Brief Summary: Primary endpoint of this study is to evaluate the pharmacokinetic characteristics of AD-117 in healthy subjects.
Study Start Date: Oct. 20
Study Type: INTERVENTIONAL
Condition:
Mixed Dyslipidemia
Intervention:
DRUG: AD-117
AD-117 1Tab., Per Oral
DRUG: AD-117A
AD-117A 1Tab., Per Oral
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Addpharma Inc.
Published by HT Digital Content Services with permission from Health Daily Digest....